Abstract
Triple-A syndrome is characterized by triad of adrenocorticotrophic hormone (ACTH)— resistant adrenal insufficiency, alacrimia and achalasia cardia. It is a rare disease and inherited by autosomal recessive pattern. Allgrove syndrome is characterized by mutation(s) in AAAS gene, located on chromosome 12q13, that codes for ALADIN protein. Most mutations produce a truncated protein, although missense and point-mutations have also been reported. Some patients with Triple-A syndrome may not have mutations in AAAS gene; in those there is no specific genotype-phenotype correlation. Although alacrimia is not the usual presenting manifestation, probably it is the earliest and most consistent feature. Achalasia cardia and adrenal insufficiency are the early and usual presenting manifestations. Neurological features appear at later age and autonomic manifestations are the most common neurological disorder. Polyneuropathy, amyotrophy, optic atrophy are the other common neurological problems. Alacrimia is diagnosed by Schirmer’s test while ahalasia cardia and adrenal insufficiency are best diagnosed by esophageal monometry and ACTH stimulated cortisol levels respectively. Alacrimia is treated with artificial tears while achalasia cardia with either pneumatic dilatation or Heller’s myotomy. Adrenal insufficiency is treated with glucocorticoid and if necessary mineralocorticoid repla
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allgrove J, Clayden GS, Grant DB et al. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978; 1:1284–1286.
Onat AM, Pehlivan Y, Buyukhatipoglu H et al. Unusual presentation of triple A syndrome mimicking Sjögren’s syndrome. Clin Rheumatol 2007; 26:1749–1751.
Gazarian M, Cowell CT, Bonney M et al. The “4 A” syndrome: adrenocortical insufficiency associated with achalasia, alacrimia, autonomic and other neurological abnormalities. Eur J Pediatr 1995; 154:18–23.
Goizet C, Catargi B, Tison F et al. Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology 2002; 26(58):962–965.
Sandrini F, Farmakidis C, Kirschner LS et al. Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. J Clin Endocrinol Metab 2001; 86:5433–5437.
Genin E, Tullio-Pelet A, Begeot F et al. Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet 2004; 41:445–449.
De Wied D. Neurotropic effects of ACTH/MSH neuropeptides. Acta Neurobiol Exp 1990; 50:353–366.
Jahn R, Padel U, Porsch P-H et al. Adrenocorticotropin hormone and a-melanocyte-stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activating cAMP dependent pathway. Euro J Biochem 1982; 126:623–629.
Onyechi Modebe. Achalasia-alacrima-acth insensitivity syndrome (Triple a syndrome) in a saudi family. Annals of Saudi Medicine 2000; 20:3–4.
Weber A, Wienker TF, Jung M et al. Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum Mol Genet 1996; 5:2061–2066.
Handschug K, Sperling S, Yoon S-JK et al. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001; 10:283–290.
Ashis Mukhyopadhya, Sumita Danda, Angela Huebner et al. Mutations of the AAAS gene in an Indian family with Allgrove’s syndrome. World J Gastroenterol 2006; 12:4764–4766.
Tullio-Pelet A, Salomon R, Hadj-Rabia S et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000; 26:332–335.
Cronshaw JM, Krutchinsky AN, Zhang W et al. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002; 158:915–927.
Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci USA 2003; 100:5823–5827.
Hirano M, Furiya Y, Asai H et al. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci USA 2006; 103:2298–2303.
Kiriyama T, Hirano M, Asai H et al. Restoration of nuclear-import failure caused by triple A syndrome and oxidative stress. Biochem Biophys Res Commun 2008; 374:631–634.
Soltani A, Arab Ameri M, Hasani Ranjbar SH. Allgrove Syndrome: A Case Report: Int J Endocrinol Metab 2007; 4:214–217.
Brooks BP, Kleta R, Stuart C et al. Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000–2005. Clin Genet 2005; 68:215–221.
Reshmi-Skarja S, Huebner A, Handschug K et al. Chromosomal fragility in patients with triple A syndrome. Am J Med Genet 2003; 117A:30–36.
Prpic I, Huebner A, Persic M et al. Triple A syndrome: genotype—phenotype assessment. Clin Genet 2003; 63:415–417.
Houlden H, Smith S, de Carvalho M et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 2002; 125:2681–2690.
Villanueva-Mendoza C, artínez-Guzmán O, Rivera-Parra D et al. Triple A or Allgrove syndrome. A case report with ophthalmic abnormalities and a novel mutation in the AAAS gene. Ophthalmic Genet 2009; 30:45–49.
Houlden H. The small, spastic and furrowed tongue of Allgrove syndrome. Neurology 2009; 72:1366.
Koehler K, Brockmann K, Krumbholz M et al. Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe. Eur J Hum Genet 2008; 16:1499–1506. Epub 2008.
Toromanovic A, Tahirovic H, Milenkovic T et al. Clinical and molecular genetic findings in a 6-year-old Bosnian boy with triple A syndrome. Eur J Pediatr 2009; 168:317–320. Epub 2008.
Kinjo S, Takemoto M, Miyako K et al. Two cases of Allgrove syndrome with mutations in the AAAS gene. Endocr J 2004; 51:473–477.
Ismail EA, Tulliot-Pelet A, Mohsen AM et al. Allgrove syndrome with features of familial dysautonomia: a novel mutation in the AAAS gene. Acta Paediatr 2006; 95:1140–1143.
Salehi M, Houlden H, Sheikh A et al. The diagnosis of adrenal insufficiency in a patient with Allgrove syndrome and a novel mutation in the ALADIN gene. Metabolism 2005; 54:200–205.
Salmaggi A, Zirilli L, Pantaleoni C et al. Late-onset triple A syndrome: a risk of overlooked or delayed diagnosis and management. Horm Res 2008; 70:364–372. Epub 2008.
Dusek T, Korsic M, Koehler K et al. A novel AAAS gene mutation (p.R194X) in a patient with triple A syndrome. Horm Res 2006; 65:171–176. Epub 2006.
Lam YY, Lo IF, Shek CC et al. Triple-A syndrome—the first Chinese patient with novel mutations in the AAAS gene. J Pediatr Endocrinol Metab 2006; 19:765–770.
Katsumata M, Hirose H, Kagami M et al. Analysis of the AAAS gene in a Japanese patient with triple A syndrome. Endocr J 2002; 49:49–53.
Milenkovic T, Koehler K, Krumbholz M et al. Three siblings with triple A syndrome with a novel frameshift mutation in the AAAS gene and a review of 17 independent patients with the frequent p.Ser263Pro mutation. Eur J Pediatr 2008; 167:1049–1055. Epub 2008.
Gong CX, Wen YR, Zhao XL et al. Allgrove syndrome in the mainland of China: clinical report and mutation analysis. Zhonghua Er Ke Za Zhi 2007; 45:422–425.
Brooks BP, Kleta R, Caruso RC et al. Triple-A syndrome with prominent ophthalmic features and a novel mutation in the AAAS gene: a case report. BMC Ophthalmol 2004; 4:7.
Schmittmann-Ohters K, Huebner A, Richter-Unruh A et al. Clinical and novel molecular findings in a 6.8-year old Turkish boy with triple A syndrome. Horm Res 2001; 56:67–72.
Buderus S, Utsch B, Huebner A et al. Dysphagia due to triple A syndrome: successful treatment of achalasia by balloon dilatation. Exp Clin Endocrinol Diabetes 2007; 115:533–536.
Roubergue A, Apartis E, Vidailhet M et al. Myoclonus and generalized digestive dysmotility in triple A syndrome with AAAS gene mutation. Mov Disord 2004; 19:344–346.
Huebner A, Kaindl AM, Knobeloch KP et al. The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex. Endocr Res 2004; 30:891–899.
Mullaney PB, Weatherhead R, Millar L et al. Keratoconjunctivitis sicca associated with achalasia of the cardia, adrenocortical insufficiency and lacrimal gland degeneration: Keratoconjunctivitis sicca secondary to lacrimal gland degeneration may parallel degenerative changes in esophageal and adrenocortical function. Ophthalmology 1998; 105:643–650.
Babu K, Murthy KR, Babu N et al. Triple A syndrome with ophthalmic manifestations in two siblings. Indian J Ophthalmol 2007; 55:304–306.
Clark AJL, Weber A. Adrenocorticotropin insensitivity syndrome. Endocr Rev 1998; 19:828–843.
Elise T, Loeper S, Jung R et al. A patient with the Triple A syndrome presenting with isolated partial adrenal androgen deficiency. 85th annual meeting, Endocrine Society, Philadelphia, PA. 2003;622.
Kimber J, McLean BN, Prevett M et al. Allgrove or 4 “A” syndrome: an autosomal recessive syndrome causing multisystem neurological disease. J Neurol Neurosurg Psychiatry 2003; 74:654–657.
Stuckey BG, Mastaglia FL, Reed WD et al. Glucocorticoid insufficiency, achalasia, alacrima with autonomic motor neuropathy. Ann Intern Med 1987; 10:61–63.
Khelif K. Achalasia of the cardia in Allgrove’s (triple A) syndrome: histopathologic study of 10 cases. Am J Surg Pathol 2003; 27:667–672.
Singh A, Shah A. Esophageal achalasia and alacrima in siblings. Indian Pediatr 2006; 43:161–163.
Thomas RJ, Sen S, Zachariah N et al. Achalasia cardia in infancy and childhood: an Indian experience. J R Coll Surg Edinb 1998; 43:103–104.
Grant DB, Barnes ND, Dumic M et al. Neurological and adrenal dysfunction in the adrenal insufficiency/ alacrima/achalasia (3A) syndrome. Arch Dis Child 1993; 68:779–782.
Grant D, Dunger D, Smith I et al. Familial glucocorticoid deficiency with achalsia of the cardia associated with a mixed neuropathy, long tract degeneration and mild dementia. Eur J Pediatr 1992; 151:85–89.
Pombo M, Deuesa J, Taborda A et al. Glucocorticoid deficiency with achalasia of the cardia and lack of lacrimation. Clin Endocrinol 1985; 23:237–243.
Ozgen AG, Ercan E, Ozutemiz O et al. The 4A syndrome association with osteoporosis. Endocr J 1999; 46:227–230.
Dumic M, Mravak-Stipetic M, Kaic Z et al. Xerostomia in patients with triple A syndrome—a newly recognized finding. Eur J Pediatr 2000; 159:885–888.
Khong PL, Peh WC, Low LC et al. Variant of the Triple A syndrome. Australas Radiol 1994; 38:222–224.
Zhang Y, Chun-Di Xu, Zaouche A et al. Diagnosis and management of esophageal achalasia in children: analysis of 13 cases. World J Pediatr 2009; 5:56–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Sarathi, V., Shah, N.S. (2010). Triple-A Syndrome. In: Ahmad, S.I. (eds) Diseases of DNA Repair. Advances in Experimental Medicine and Biology, vol 685. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6448-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6448-9_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6447-2
Online ISBN: 978-1-4419-6448-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)